A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients
Clinical trial NCT01057628 · COMPLETED
Trial details
- NCT number
- NCT01057628
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-13
- Primary completion
- 2010-11-06
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.